Exchange: NASDAQ·Updated 07:30 PM EDT
MIRM logo

MIRM Mirum Pharmaceuticals Inc

$100.90
$0.27
(0.27%)
Today
Closed $100.90
$0.00
(0.00%)
After Hours
EarningsNov 4
Mkt Cap$6.55B
Vol350,960.00

About MIRM

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products pipeline includes Maralixibat, Cholbam, Ctexli, Volixibat, Brelovitug, MRM-3379, and Zilurgisertib. The company was founded by Niall O'Donnel, Michael G. Grey, and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
33

Bearish Sentiment

How do you feel about MIRM?

Advertisement|Remove ads.